Estradiol–estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
Abstract
Estrogens are related with the growth and development of target tissues and play a critical role in breast cancer progression. The effects of estrogens are mediated by the estrogen receptors ERα and ERβ, which are members of the nuclear steroid receptor superfamily. To date, it is not known how these hormones elicit many of their effects on extracellular matrix molecules and how these effects can be connected with ER expression. For this purpose, the effect of estradiol on ER expression as well as on proteoglycan and metalloproteinase expression was studied. The effect of E2 on extracellular matrix molecule expression has been studied using ERα suppression in breast cancer cells. Our studies using ERα-positive MCF-7 cells show that estradiol affects the expression of syndecan-2, but not of syndecan-4, through ERα. Furthermore, the ability of estradiol to affect MMP-9 and TIMP-1 expression is connected with ERα status. Together, these data demonstrate the significant role of ERα on mediating the effect of estradiol on extracellular matrix molecules.
Keywords: Proteoglycans, Metalloproteinases, Tissue inhibitors of metalloproteinases, Estradiol, Breast cancer, Estrogen receptor α
Abbreviations: E2, estradiol, PG, proteoglycan, MMP, matrix metalloproteinase, TIMP, tissue inhibitor of metalloproteinase, ECM, extracellular matrix, ER, estrogen receptor, ERE, estrogen responsive element
To access this article, please choose from the options below
PII: S1574-7891(08)00072-0
doi:10.1016/j.molonc.2008.06.002
© 2008 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved.

